Erratum to: Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study.
作者信息
Ma Jian-Da, Wei Xiu-Ning, Zheng Dong-Hui, Mo Ying-Qian, Chen Le-Feng, Zhang Xiang, Li Jin-Hua, Dai Lie
机构信息
Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
出版信息
Arthritis Res Ther. 2015 Nov 4;17:311. doi: 10.1186/s13075-015-0837-5.
Abstract
摘要
相似文献
1
Erratum to: Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study.《类风湿关节炎中持续3至6个月血清基质金属蛋白酶-3升高预测一年影像学进展：一项前瞻性队列研究》的勘误
Arthritis Res Ther. 2015 Nov 4;17:311. doi: 10.1186/s13075-015-0837-5.
2
Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.早期类风湿关节炎患者尿葡萄糖基-半乳糖基-吡啶啉和II型胶原C末端肽基线水平与关节破坏进展的相关性
Arthritis Rheum. 2002 Jan;46(1):21-30. doi: 10.1002/1529-0131(200201)46:1<21::AID-ART10061>3.0.CO;2-Q.
3
Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort.血清 IL-6 和 IL-21 与早期类风湿关节炎中 B 细胞活化和结构进展的标志物相关：来自 ESPOIR 队列的结果。
Ann Rheum Dis. 2012 Jul;71(7):1243-8. doi: 10.1136/annrheumdis-2011-200975. Epub 2012 Apr 24.
4
5
7
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.来氟米特与甲氨蝶呤治疗活动性类风湿关节炎的两年双盲随机对照试验。类风湿关节炎治疗中来氟米特应用试验研究组。
Arthritis Rheum. 2001 Sep;44(9):1984-92. doi: 10.1002/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B.
8
[Diagnosis and prediction of joint destruction found in patients with rheumatoid arthritis using by biochemical markers].[利用生化标志物对类风湿关节炎患者关节破坏的诊断与预测]
Nihon Rinsho. 2005 Sep;63(9):1586-93.
9
[Dynamics of matrix metalloproteinase (MMP)-13 in the patients with rheumatoid arthritis].[类风湿关节炎患者基质金属蛋白酶（MMP）-13的动态变化]
Ryumachi. 2002 Feb;42(1):60-9.
10
Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.血清基质金属蛋白酶-3 水平与青少年特发性关节炎中附着点相关关节炎类别的疾病活动度相关。
J Rheumatol. 2011 Nov;38(11):2482-7. doi: 10.3899/jrheum.110352. Epub 2011 Sep 1.
引用本文的文献
1
Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics.基于系统药理学和多组学探索雷公藤红素治疗类风湿关节炎的机制。
Sci Rep. 2024 Jan 18;14(1):1604. doi: 10.1038/s41598-023-48248-5.
2
, , and Gene Polymorphism Susceptibility in Onset of Arthritis.自身免疫性疾病关节炎发病相关的基因多态性易感性研究
Genet Res (Camb). 2022 Sep 20;2022:9208765. doi: 10.1155/2022/9208765. eCollection 2022.
本文引用的文献
1
Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study.持续3至6个月血清基质金属蛋白酶-3水平升高可预测类风湿关节炎的一年影像学进展：一项前瞻性队列研究。
Arthritis Res Ther. 2015 Oct 14;17:289. doi: 10.1186/s13075-015-0803-2.
Zotero 插件